SCHEMBL6517302

SCHEMBL6517302

COc1cc2c(cc1S(=O)(=O)c1ccc(C(O)c3ccccc3Cl)cc1)CCN(C)CC2

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 3/20 0.42
DRD3 P35462 3/20 0.42
HTR2A P28223 2/20 0.42
HTR2C P28335 2/20 0.42
HTR6 P50406 2/20 0.42
DRD1 P21728 4/20 0.40
DRD5 P21918 4/20 0.40
DRD4 P21917 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
ALDH1A1 P00352 5/20 0.38
HPGD P15428 1/20 0.37
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
ALK Q9UM73 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6509996 0.87 HTR6 (0.39) DRD2DRD3HTR2AHTR2CHTR6
SCHEMBL6517175 0.83 KMT2A (0.43) DRD2DRD3HTR2AHTR2CHTR6
SCHEMBL6509180 0.82 DRD2 (0.41) DRD2DRD3HTR2AHTR2CHTR6
SCHEMBL6513803 0.78 DRD2 (0.38) DRD2DRD3HTR2AHTR2CHTR6
SCHEMBL6506073 0.78 LMNA (0.44) DRD2DRD3HTR2AHTR2CHTR6
SCHEMBL3907828 0.75 MAOA (0.47) DRD2DRD3HTR2AHTR2CHTR6
SCHEMBL3892485 0.75 MAOA (0.47) DRD2DRD3HTR2AHTR2CHTR6
SCHEMBL3903162 0.75 MAOB (0.48) DRD2DRD3HTR2AHTR2CHTR6
SCHEMBL3894400 0.75 DRD1 (0.46) DRD2DRD3HTR2AHTR2CHTR6
SCHEMBL6502583 0.75 LMNA (0.48) DRD2DRD3HTR2AHTR2CHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016891-A1 7-PHENYLSULFONYL-TETRAHYDRO-3-BENZAZEPINE DERIVATIVES AS ANTIPSYCHOTIC AGENTS GLAXO GROUP LIMITED (GB) 2005-02-24 WO claimed
WO-2005016891-A1 7-PHENYLSULFONYL-TETRAHYDRO-3-BENZAZEPINE DERIVATIVES AS ANTIPSYCHOTIC AGENTS GLAXO GROUP LIMITED (GB) 2005-02-24 WO disclosed